Home » Topics » Regulatory » Patents

Patents
RSS

Inhibitors of ICE activity described by Vertex

Sep. 14, 1998

Preparation and use of peptide bradykinin B2 receptor agonists described by Fournier

Sep. 14, 1998

Antiplatelet compounds developed by Merck & Co.

Sep. 14, 1998

Inhibitors of sPLA2 claimed by Lilly for septic shock, etc.

Sep. 14, 1998

Synthelabo compounds act as 5-HT receptor ligands

Sep. 14, 1998

Fujisawa scientists synthesize new series of vasopressin antagonists

Sep. 10, 1998

Natural nonpeptide inhibitors of protein farnesyltransferase discovered at Merck & Co.

Sep. 10, 1998

Schering-Plough prepares arylalkylamines as neurokinin antagonists

Sep. 10, 1998

U.S. university researchers discover nucleoside analogues for EBV

Sep. 9, 1998

New diagnostic agents described in patent literature by Schering AG

Sep. 9, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 15, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...